8/F, 35 QRC Building, No.35 Queens Road, Central, Hong Kong
hkmagicure@gmail.com
  • Cabometyx (Cabozantinib)

    Cabozantinib, developed by Exelixis Biopharmaceuticals, USA, is a broad-spectrum anticancer drug with multiple targets, including MET, VEGFR1/2/3, ROS1...

    Lung CancerLiver CancerKidney CancerThyroid Cancer
  • Of 1Page1Record